Global Fibrinogen Market Growth 2025-2031
The report requires updating with new data and is sent in 48 hours after order is placed.
The global Fibrinogen market size is predicted to grow from US$ 1034 million in 2025 to US$ 2502 million in 2031; it is expected to grow at a CAGR of 15.9% from 2025 to 2031.
Fibrinogen (factor I) is a glycoprotein in vertebrates that helps in the formation of blood clots. Fibrinogen Concentrate is used as a medicine for blood disease. Fibrinogen concentrate is a preparation of coagulation factors prepared from pooled plasma. Currently, only RiaSTAP (CSL Behring) is licensed in a number of countries for multiple indications including treating acute bleeding episodes with Hypofibrinogenemia. Other manufacturer’s products are justly used in local region or countries.
Global core fibrinogen manufacturers include CSL Behring, LFB Group and Shanghai RAAS Blood Products etc. The top 1 companies hold a share about 52%. North America is the largest market, with a share about 31%, followed by Europe and Asia Pacific with the share about 28% and 26%.
LP Information, Inc. (LPI) ' newest research report, the “Fibrinogen Industry Forecast” looks at past sales and reviews total world Fibrinogen sales in 2024, providing a comprehensive analysis by region and market sector of projected Fibrinogen sales for 2025 through 2031. With Fibrinogen sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Fibrinogen industry.
This Insight Report provides a comprehensive analysis of the global Fibrinogen landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Fibrinogen portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Fibrinogen market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Fibrinogen and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Fibrinogen.
This report presents a comprehensive overview, market shares, and growth opportunities of Fibrinogen market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Fibrinogen market?
What factors are driving Fibrinogen market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Fibrinogen market opportunities vary by end market size?
How does Fibrinogen break out by Type, by Application?
The global Fibrinogen market size is predicted to grow from US$ 1034 million in 2025 to US$ 2502 million in 2031; it is expected to grow at a CAGR of 15.9% from 2025 to 2031.
Fibrinogen (factor I) is a glycoprotein in vertebrates that helps in the formation of blood clots. Fibrinogen Concentrate is used as a medicine for blood disease. Fibrinogen concentrate is a preparation of coagulation factors prepared from pooled plasma. Currently, only RiaSTAP (CSL Behring) is licensed in a number of countries for multiple indications including treating acute bleeding episodes with Hypofibrinogenemia. Other manufacturer’s products are justly used in local region or countries.
Global core fibrinogen manufacturers include CSL Behring, LFB Group and Shanghai RAAS Blood Products etc. The top 1 companies hold a share about 52%. North America is the largest market, with a share about 31%, followed by Europe and Asia Pacific with the share about 28% and 26%.
LP Information, Inc. (LPI) ' newest research report, the “Fibrinogen Industry Forecast” looks at past sales and reviews total world Fibrinogen sales in 2024, providing a comprehensive analysis by region and market sector of projected Fibrinogen sales for 2025 through 2031. With Fibrinogen sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Fibrinogen industry.
This Insight Report provides a comprehensive analysis of the global Fibrinogen landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Fibrinogen portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Fibrinogen market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Fibrinogen and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Fibrinogen.
This report presents a comprehensive overview, market shares, and growth opportunities of Fibrinogen market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Human Fibrinogen
- Animal Fibrinogen
- Congenital Fibrinogen Deficiency
- Surgical Procedures
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- CSL Behring
- LFB Group
- Shanghai RAAS Blood Products
- Jiangxi Boya Bio-Pharmaceutical
- Hualan Biological Engineering
- Harbin Pacific Biopharmaceutical
- GREEN CROSS
- Shanghai XinXing Medical
- Taibang Biologic
- Octapharma
What is the 10-year outlook for the global Fibrinogen market?
What factors are driving Fibrinogen market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Fibrinogen market opportunities vary by end market size?
How does Fibrinogen break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Fibrinogen Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Fibrinogen by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Fibrinogen by Country/Region, 2020, 2024 & 2031
2.2 Fibrinogen Segment by Type
2.2.1 Human Fibrinogen
2.2.2 Animal Fibrinogen
2.3 Fibrinogen Sales by Type
2.3.1 Global Fibrinogen Sales Market Share by Type (2020-2025)
2.3.2 Global Fibrinogen Revenue and Market Share by Type (2020-2025)
2.3.3 Global Fibrinogen Sale Price by Type (2020-2025)
2.4 Fibrinogen Segment by Application
2.4.1 Congenital Fibrinogen Deficiency
2.4.2 Surgical Procedures
2.4.3 Others
2.5 Fibrinogen Sales by Application
2.5.1 Global Fibrinogen Sale Market Share by Application (2020-2025)
2.5.2 Global Fibrinogen Revenue and Market Share by Application (2020-2025)
2.5.3 Global Fibrinogen Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Fibrinogen Breakdown Data by Company
3.1.1 Global Fibrinogen Annual Sales by Company (2020-2025)
3.1.2 Global Fibrinogen Sales Market Share by Company (2020-2025)
3.2 Global Fibrinogen Annual Revenue by Company (2020-2025)
3.2.1 Global Fibrinogen Revenue by Company (2020-2025)
3.2.2 Global Fibrinogen Revenue Market Share by Company (2020-2025)
3.3 Global Fibrinogen Sale Price by Company
3.4 Key Manufacturers Fibrinogen Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Fibrinogen Product Location Distribution
3.4.2 Players Fibrinogen Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR FIBRINOGEN BY GEOGRAPHIC REGION
4.1 World Historic Fibrinogen Market Size by Geographic Region (2020-2025)
4.1.1 Global Fibrinogen Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Fibrinogen Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Fibrinogen Market Size by Country/Region (2020-2025)
4.2.1 Global Fibrinogen Annual Sales by Country/Region (2020-2025)
4.2.2 Global Fibrinogen Annual Revenue by Country/Region (2020-2025)
4.3 Americas Fibrinogen Sales Growth
4.4 APAC Fibrinogen Sales Growth
4.5 Europe Fibrinogen Sales Growth
4.6 Middle East & Africa Fibrinogen Sales Growth
5 AMERICAS
5.1 Americas Fibrinogen Sales by Country
5.1.1 Americas Fibrinogen Sales by Country (2020-2025)
5.1.2 Americas Fibrinogen Revenue by Country (2020-2025)
5.2 Americas Fibrinogen Sales by Type (2020-2025)
5.3 Americas Fibrinogen Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Fibrinogen Sales by Region
6.1.1 APAC Fibrinogen Sales by Region (2020-2025)
6.1.2 APAC Fibrinogen Revenue by Region (2020-2025)
6.2 APAC Fibrinogen Sales by Type (2020-2025)
6.3 APAC Fibrinogen Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Fibrinogen by Country
7.1.1 Europe Fibrinogen Sales by Country (2020-2025)
7.1.2 Europe Fibrinogen Revenue by Country (2020-2025)
7.2 Europe Fibrinogen Sales by Type (2020-2025)
7.3 Europe Fibrinogen Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Fibrinogen by Country
8.1.1 Middle East & Africa Fibrinogen Sales by Country (2020-2025)
8.1.2 Middle East & Africa Fibrinogen Revenue by Country (2020-2025)
8.2 Middle East & Africa Fibrinogen Sales by Type (2020-2025)
8.3 Middle East & Africa Fibrinogen Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Fibrinogen
10.3 Manufacturing Process Analysis of Fibrinogen
10.4 Industry Chain Structure of Fibrinogen
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Fibrinogen Distributors
11.3 Fibrinogen Customer
12 WORLD FORECAST REVIEW FOR FIBRINOGEN BY GEOGRAPHIC REGION
12.1 Global Fibrinogen Market Size Forecast by Region
12.1.1 Global Fibrinogen Forecast by Region (2026-2031)
12.1.2 Global Fibrinogen Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Fibrinogen Forecast by Type (2026-2031)
12.7 Global Fibrinogen Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 CSL Behring
13.1.1 CSL Behring Company Information
13.1.2 CSL Behring Fibrinogen Product Portfolios and Specifications
13.1.3 CSL Behring Fibrinogen Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 CSL Behring Main Business Overview
13.1.5 CSL Behring Latest Developments
13.2 LFB Group
13.2.1 LFB Group Company Information
13.2.2 LFB Group Fibrinogen Product Portfolios and Specifications
13.2.3 LFB Group Fibrinogen Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 LFB Group Main Business Overview
13.2.5 LFB Group Latest Developments
13.3 Shanghai RAAS Blood Products
13.3.1 Shanghai RAAS Blood Products Company Information
13.3.2 Shanghai RAAS Blood Products Fibrinogen Product Portfolios and Specifications
13.3.3 Shanghai RAAS Blood Products Fibrinogen Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Shanghai RAAS Blood Products Main Business Overview
13.3.5 Shanghai RAAS Blood Products Latest Developments
13.4 Jiangxi Boya Bio-Pharmaceutical
13.4.1 Jiangxi Boya Bio-Pharmaceutical Company Information
13.4.2 Jiangxi Boya Bio-Pharmaceutical Fibrinogen Product Portfolios and Specifications
13.4.3 Jiangxi Boya Bio-Pharmaceutical Fibrinogen Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Jiangxi Boya Bio-Pharmaceutical Main Business Overview
13.4.5 Jiangxi Boya Bio-Pharmaceutical Latest Developments
13.5 Hualan Biological Engineering
13.5.1 Hualan Biological Engineering Company Information
13.5.2 Hualan Biological Engineering Fibrinogen Product Portfolios and Specifications
13.5.3 Hualan Biological Engineering Fibrinogen Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Hualan Biological Engineering Main Business Overview
13.5.5 Hualan Biological Engineering Latest Developments
13.6 Harbin Pacific Biopharmaceutical
13.6.1 Harbin Pacific Biopharmaceutical Company Information
13.6.2 Harbin Pacific Biopharmaceutical Fibrinogen Product Portfolios and Specifications
13.6.3 Harbin Pacific Biopharmaceutical Fibrinogen Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Harbin Pacific Biopharmaceutical Main Business Overview
13.6.5 Harbin Pacific Biopharmaceutical Latest Developments
13.7 GREEN CROSS
13.7.1 GREEN CROSS Company Information
13.7.2 GREEN CROSS Fibrinogen Product Portfolios and Specifications
13.7.3 GREEN CROSS Fibrinogen Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 GREEN CROSS Main Business Overview
13.7.5 GREEN CROSS Latest Developments
13.8 Shanghai XinXing Medical
13.8.1 Shanghai XinXing Medical Company Information
13.8.2 Shanghai XinXing Medical Fibrinogen Product Portfolios and Specifications
13.8.3 Shanghai XinXing Medical Fibrinogen Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Shanghai XinXing Medical Main Business Overview
13.8.5 Shanghai XinXing Medical Latest Developments
13.9 Taibang Biologic
13.9.1 Taibang Biologic Company Information
13.9.2 Taibang Biologic Fibrinogen Product Portfolios and Specifications
13.9.3 Taibang Biologic Fibrinogen Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Taibang Biologic Main Business Overview
13.9.5 Taibang Biologic Latest Developments
13.10 Octapharma
13.10.1 Octapharma Company Information
13.10.2 Octapharma Fibrinogen Product Portfolios and Specifications
13.10.3 Octapharma Fibrinogen Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Octapharma Main Business Overview
13.10.5 Octapharma Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OFTABLES
Table 1.Fibrinogen Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2.Fibrinogen Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of HumanFibrinogen
Table 4. Major Players of AnimalFibrinogen
Table 5. GlobalFibrinogen Sales byType (2020-2025) & (Kg)
Table 6. GlobalFibrinogen Sales Market Share byType (2020-2025)
Table 7. GlobalFibrinogen Revenue byType (2020-2025) & ($ million)
Table 8. GlobalFibrinogen Revenue Market Share byType (2020-2025)
Table 9. GlobalFibrinogen Sale Price byType (2020-2025) & (US$/g)
Table 10. GlobalFibrinogen Sale by Application (2020-2025) & (Kg)
Table 11. GlobalFibrinogen Sale Market Share by Application (2020-2025)
Table 12. GlobalFibrinogen Revenue by Application (2020-2025) & ($ million)
Table 13. GlobalFibrinogen Revenue Market Share by Application (2020-2025)
Table 14. GlobalFibrinogen Sale Price by Application (2020-2025) & (US$/g)
Table 15. GlobalFibrinogen Sales by Company (2020-2025) & (Kg)
Table 16. GlobalFibrinogen Sales Market Share by Company (2020-2025)
Table 17. GlobalFibrinogen Revenue by Company (2020-2025) & ($ millions)
Table 18. GlobalFibrinogen Revenue Market Share by Company (2020-2025)
Table 19. GlobalFibrinogen Sale Price by Company (2020-2025) & (US$/g)
Table 20. Key ManufacturersFibrinogen Producing Area Distribution and Sales Area
Table 21. PlayersFibrinogen Products Offered
Table 22.Fibrinogen Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. GlobalFibrinogen Sales by Geographic Region (2020-2025) & (Kg)
Table 26. GlobalFibrinogen Sales Market Share Geographic Region (2020-2025)
Table 27. GlobalFibrinogen Revenue by Geographic Region (2020-2025) & ($ millions)
Table 28. GlobalFibrinogen Revenue Market Share by Geographic Region (2020-2025)
Table 29. GlobalFibrinogen Sales by Country/Region (2020-2025) & (Kg)
Table 30. GlobalFibrinogen Sales Market Share by Country/Region (2020-2025)
Table 31. GlobalFibrinogen Revenue by Country/Region (2020-2025) & ($ millions)
Table 32. GlobalFibrinogen Revenue Market Share by Country/Region (2020-2025)
Table 33. AmericasFibrinogen Sales by Country (2020-2025) & (Kg)
Table 34. AmericasFibrinogen Sales Market Share by Country (2020-2025)
Table 35. AmericasFibrinogen Revenue by Country (2020-2025) & ($ millions)
Table 36. AmericasFibrinogen Sales byType (2020-2025) & (Kg)
Table 37. AmericasFibrinogen Sales by Application (2020-2025) & (Kg)
Table 38. APACFibrinogen Sales by Region (2020-2025) & (Kg)
Table 39. APACFibrinogen Sales Market Share by Region (2020-2025)
Table 40. APACFibrinogen Revenue by Region (2020-2025) & ($ millions)
Table 41. APACFibrinogen Sales byType (2020-2025) & (Kg)
Table 42. APACFibrinogen Sales by Application (2020-2025) & (Kg)
Table 43. EuropeFibrinogen Sales by Country (2020-2025) & (Kg)
Table 44. EuropeFibrinogen Revenue by Country (2020-2025) & ($ millions)
Table 45. EuropeFibrinogen Sales byType (2020-2025) & (Kg)
Table 46. EuropeFibrinogen Sales by Application (2020-2025) & (Kg)
Table 47. Middle East & AfricaFibrinogen Sales by Country (2020-2025) & (Kg)
Table 48. Middle East & AfricaFibrinogen Revenue Market Share by Country (2020-2025)
Table 49. Middle East & AfricaFibrinogen Sales byType (2020-2025) & (Kg)
Table 50. Middle East & AfricaFibrinogen Sales by Application (2020-2025) & (Kg)
Table 51. Key Market Drivers & Growth Opportunities ofFibrinogen
Table 52. Key Market Challenges & Risks ofFibrinogen
Table 53. Key IndustryTrends ofFibrinogen
Table 54.Fibrinogen Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56.Fibrinogen Distributors List
Table 57.Fibrinogen Customer List
Table 58. GlobalFibrinogen SalesForecast by Region (2026-2031) & (Kg)
Table 59. GlobalFibrinogen RevenueForecast by Region (2026-2031) & ($ millions)
Table 60. AmericasFibrinogen SalesForecast by Country (2026-2031) & (Kg)
Table 61. AmericasFibrinogen Annual RevenueForecast by Country (2026-2031) & ($ millions)
Table 62. APACFibrinogen SalesForecast by Region (2026-2031) & (Kg)
Table 63. APACFibrinogen Annual RevenueForecast by Region (2026-2031) & ($ millions)
Table 64. EuropeFibrinogen SalesForecast by Country (2026-2031) & (Kg)
Table 65. EuropeFibrinogen RevenueForecast by Country (2026-2031) & ($ millions)
Table 66. Middle East & AfricaFibrinogen SalesForecast by Country (2026-2031) & (Kg)
Table 67. Middle East & AfricaFibrinogen RevenueForecast by Country (2026-2031) & ($ millions)
Table 68. GlobalFibrinogen SalesForecast byType (2026-2031) & (Kg)
Table 69. GlobalFibrinogen RevenueForecast byType (2026-2031) & ($ millions)
Table 70. GlobalFibrinogen SalesForecast by Application (2026-2031) & (Kg)
Table 71. GlobalFibrinogen RevenueForecast by Application (2026-2031) & ($ millions)
Table 72. CSL Behring Basic Information,Fibrinogen Manufacturing Base, Sales Area and Its Competitors
Table 73. CSL BehringFibrinogen Product Portfolios and Specifications
Table 74. CSL BehringFibrinogen Sales (Kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2020-2025)
Table 75. CSL Behring Main Business
Table 76. CSL Behring Latest Developments
Table 77. LFB Group Basic Information,Fibrinogen Manufacturing Base, Sales Area and Its Competitors
Table 78. LFB GroupFibrinogen Product Portfolios and Specifications
Table 79. LFB GroupFibrinogen Sales (Kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2020-2025)
Table 80. LFB Group Main Business
Table 81. LFB Group Latest Developments
Table 82. Shanghai RAAS Blood Products Basic Information,Fibrinogen Manufacturing Base, Sales Area and Its Competitors
Table 83. Shanghai RAAS Blood ProductsFibrinogen Product Portfolios and Specifications
Table 84. Shanghai RAAS Blood ProductsFibrinogen Sales (Kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2020-2025)
Table 85. Shanghai RAAS Blood Products Main Business
Table 86. Shanghai RAAS Blood Products Latest Developments
Table 87. Jiangxi Boya Bio-Pharmaceutical Basic Information,Fibrinogen Manufacturing Base, Sales Area and Its Competitors
Table 88. Jiangxi Boya Bio-PharmaceuticalFibrinogen Product Portfolios and Specifications
Table 89. Jiangxi Boya Bio-PharmaceuticalFibrinogen Sales (Kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2020-2025)
Table 90. Jiangxi Boya Bio-Pharmaceutical Main Business
Table 91. Jiangxi Boya Bio-Pharmaceutical Latest Developments
Table 92. Hualan Biological Engineering Basic Information,Fibrinogen Manufacturing Base, Sales Area and Its Competitors
Table 93. Hualan Biological EngineeringFibrinogen Product Portfolios and Specifications
Table 94. Hualan Biological EngineeringFibrinogen Sales (Kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2020-2025)
Table 95. Hualan Biological Engineering Main Business
Table 96. Hualan Biological Engineering Latest Developments
Table 97. Harbin Pacific Biopharmaceutical Basic Information,Fibrinogen Manufacturing Base, Sales Area and Its Competitors
Table 98. Harbin Pacific BiopharmaceuticalFibrinogen Product Portfolios and Specifications
Table 99. Harbin Pacific BiopharmaceuticalFibrinogen Sales (Kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2020-2025)
Table 100. Harbin Pacific Biopharmaceutical Main Business
Table 101. Harbin Pacific Biopharmaceutical Latest Developments
Table 102. GREEN CROSS Basic Information,Fibrinogen Manufacturing Base, Sales Area and Its Competitors
Table 103. GREEN CROSSFibrinogen Product Portfolios and Specifications
Table 104. GREEN CROSSFibrinogen Sales (Kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2020-2025)
Table 105. GREEN CROSS Main Business
Table 106. GREEN CROSS Latest Developments
Table 107. Shanghai XinXing Medical Basic Information,Fibrinogen Manufacturing Base, Sales Area and Its Competitors
Table 108. Shanghai XinXing MedicalFibrinogen Product Portfolios and Specifications
Table 109. Shanghai XinXing MedicalFibrinogen Sales (Kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2020-2025)
Table 110. Shanghai XinXing Medical Main Business
Table 111. Shanghai XinXing Medical Latest Developments
Table 112.Taibang Biologic Basic Information,Fibrinogen Manufacturing Base, Sales Area and Its Competitors
Table 113.Taibang BiologicFibrinogen Product Portfolios and Specifications
Table 114.Taibang BiologicFibrinogen Sales (Kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2020-2025)
Table 115.Taibang Biologic Main Business
Table 116.Taibang Biologic Latest Developments
Table 117. Octapharma Basic Information,Fibrinogen Manufacturing Base, Sales Area and Its Competitors
Table 118. OctapharmaFibrinogen Product Portfolios and Specifications
Table 119. OctapharmaFibrinogen Sales (Kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2020-2025)
Table 120. Octapharma Main Business
Table 121. Octapharma Latest Developments
LIST OFFIGURES
Figure 1. Picture ofFibrinogen
Figure 2.Fibrinogen Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. GlobalFibrinogen Sales Growth Rate 2020-2031 (Kg)
Figure 7. GlobalFibrinogen Revenue Growth Rate 2020-2031 ($ millions)
Figure 8.Fibrinogen Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9.Fibrinogen Sales Market Share by Country/Region (2024)
Figure 10.Fibrinogen Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of HumanFibrinogen
Figure 12. Product Picture of AnimalFibrinogen
Figure 13. GlobalFibrinogen Sales Market Share byType in 2025
Figure 14. GlobalFibrinogen Revenue Market Share byType (2020-2025)
Figure 15.Fibrinogen Consumed in CongenitalFibrinogen Deficiency
Figure 16. GlobalFibrinogen Market: CongenitalFibrinogen Deficiency (2020-2025) & (Kg)
Figure 17.Fibrinogen Consumed in Surgical Procedures
Figure 18. GlobalFibrinogen Market: Surgical Procedures (2020-2025) & (Kg)
Figure 19.Fibrinogen Consumed in Others
Figure 20. GlobalFibrinogen Market: Others (2020-2025) & (Kg)
Figure 21. GlobalFibrinogen Sale Market Share by Application (2024)
Figure 22. GlobalFibrinogen Revenue Market Share by Application in 2025
Figure 23.Fibrinogen Sales by Company in 2025 (Kg)
Figure 24. GlobalFibrinogen Sales Market Share by Company in 2025
Figure 25.Fibrinogen Revenue by Company in 2025 ($ millions)
Figure 26. GlobalFibrinogen Revenue Market Share by Company in 2025
Figure 27. GlobalFibrinogen Sales Market Share by Geographic Region (2020-2025)
Figure 28. GlobalFibrinogen Revenue Market Share by Geographic Region in 2025
Figure 29. AmericasFibrinogen Sales 2020-2025 (Kg)
Figure 30. AmericasFibrinogen Revenue 2020-2025 ($ millions)
Figure 31. APACFibrinogen Sales 2020-2025 (Kg)
Figure 32. APACFibrinogen Revenue 2020-2025 ($ millions)
Figure 33. EuropeFibrinogen Sales 2020-2025 (Kg)
Figure 34. EuropeFibrinogen Revenue 2020-2025 ($ millions)
Figure 35. Middle East & AfricaFibrinogen Sales 2020-2025 (Kg)
Figure 36. Middle East & AfricaFibrinogen Revenue 2020-2025 ($ millions)
Figure 37. AmericasFibrinogen Sales Market Share by Country in 2025
Figure 38. AmericasFibrinogen Revenue Market Share by Country (2020-2025)
Figure 39. AmericasFibrinogen Sales Market Share byType (2020-2025)
Figure 40. AmericasFibrinogen Sales Market Share by Application (2020-2025)
Figure 41. United StatesFibrinogen Revenue Growth 2020-2025 ($ millions)
Figure 42. CanadaFibrinogen Revenue Growth 2020-2025 ($ millions)
Figure 43. MexicoFibrinogen Revenue Growth 2020-2025 ($ millions)
Figure 44. BrazilFibrinogen Revenue Growth 2020-2025 ($ millions)
Figure 45. APACFibrinogen Sales Market Share by Region in 2025
Figure 46. APACFibrinogen Revenue Market Share by Region (2020-2025)
Figure 47. APACFibrinogen Sales Market Share byType (2020-2025)
Figure 48. APACFibrinogen Sales Market Share by Application (2020-2025)
Figure 49. ChinaFibrinogen Revenue Growth 2020-2025 ($ millions)
Figure 50. JapanFibrinogen Revenue Growth 2020-2025 ($ millions)
Figure 51. South KoreaFibrinogen Revenue Growth 2020-2025 ($ millions)
Figure 52. Southeast AsiaFibrinogen Revenue Growth 2020-2025 ($ millions)
Figure 53. IndiaFibrinogen Revenue Growth 2020-2025 ($ millions)
Figure 54. AustraliaFibrinogen Revenue Growth 2020-2025 ($ millions)
Figure 55. ChinaTaiwanFibrinogen Revenue Growth 2020-2025 ($ millions)
Figure 56. EuropeFibrinogen Sales Market Share by Country in 2025
Figure 57. EuropeFibrinogen Revenue Market Share by Country (2020-2025)
Figure 58. EuropeFibrinogen Sales Market Share byType (2020-2025)
Figure 59. EuropeFibrinogen Sales Market Share by Application (2020-2025)
Figure 60. GermanyFibrinogen Revenue Growth 2020-2025 ($ millions)
Figure 61.FranceFibrinogen Revenue Growth 2020-2025 ($ millions)
Figure 62. UKFibrinogen Revenue Growth 2020-2025 ($ millions)
Figure 63. ItalyFibrinogen Revenue Growth 2020-2025 ($ millions)
Figure 64. RussiaFibrinogen Revenue Growth 2020-2025 ($ millions)
Figure 65. Middle East & AfricaFibrinogen Sales Market Share by Country (2020-2025)
Figure 66. Middle East & AfricaFibrinogen Sales Market Share byType (2020-2025)
Figure 67. Middle East & AfricaFibrinogen Sales Market Share by Application (2020-2025)
Figure 68. EgyptFibrinogen Revenue Growth 2020-2025 ($ millions)
Figure 69. South AfricaFibrinogen Revenue Growth 2020-2025 ($ millions)
Figure 70. IsraelFibrinogen Revenue Growth 2020-2025 ($ millions)
Figure 71.TurkeyFibrinogen Revenue Growth 2020-2025 ($ millions)
Figure 72. GCC CountriesFibrinogen Revenue Growth 2020-2025 ($ millions)
Figure 73. Manufacturing Cost Structure Analysis ofFibrinogen in 2025
Figure 74. Manufacturing Process Analysis ofFibrinogen
Figure 75. Industry Chain Structure ofFibrinogen
Figure 76. Channels of Distribution
Figure 77. GlobalFibrinogen Sales MarketForecast by Region (2026-2031)
Figure 78. GlobalFibrinogen Revenue Market ShareForecast by Region (2026-2031)
Figure 79. GlobalFibrinogen Sales Market ShareForecast byType (2026-2031)
Figure 80. GlobalFibrinogen Revenue Market ShareForecast byType (2026-2031)
Figure 81. GlobalFibrinogen Sales Market ShareForecast by Application (2026-2031)
Figure 82. GlobalFibrinogen Revenue Market ShareForecast by Application (2026-2031)
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Fibrinogen Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Fibrinogen by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Fibrinogen by Country/Region, 2020, 2024 & 2031
2.2 Fibrinogen Segment by Type
2.2.1 Human Fibrinogen
2.2.2 Animal Fibrinogen
2.3 Fibrinogen Sales by Type
2.3.1 Global Fibrinogen Sales Market Share by Type (2020-2025)
2.3.2 Global Fibrinogen Revenue and Market Share by Type (2020-2025)
2.3.3 Global Fibrinogen Sale Price by Type (2020-2025)
2.4 Fibrinogen Segment by Application
2.4.1 Congenital Fibrinogen Deficiency
2.4.2 Surgical Procedures
2.4.3 Others
2.5 Fibrinogen Sales by Application
2.5.1 Global Fibrinogen Sale Market Share by Application (2020-2025)
2.5.2 Global Fibrinogen Revenue and Market Share by Application (2020-2025)
2.5.3 Global Fibrinogen Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Fibrinogen Breakdown Data by Company
3.1.1 Global Fibrinogen Annual Sales by Company (2020-2025)
3.1.2 Global Fibrinogen Sales Market Share by Company (2020-2025)
3.2 Global Fibrinogen Annual Revenue by Company (2020-2025)
3.2.1 Global Fibrinogen Revenue by Company (2020-2025)
3.2.2 Global Fibrinogen Revenue Market Share by Company (2020-2025)
3.3 Global Fibrinogen Sale Price by Company
3.4 Key Manufacturers Fibrinogen Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Fibrinogen Product Location Distribution
3.4.2 Players Fibrinogen Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR FIBRINOGEN BY GEOGRAPHIC REGION
4.1 World Historic Fibrinogen Market Size by Geographic Region (2020-2025)
4.1.1 Global Fibrinogen Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Fibrinogen Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Fibrinogen Market Size by Country/Region (2020-2025)
4.2.1 Global Fibrinogen Annual Sales by Country/Region (2020-2025)
4.2.2 Global Fibrinogen Annual Revenue by Country/Region (2020-2025)
4.3 Americas Fibrinogen Sales Growth
4.4 APAC Fibrinogen Sales Growth
4.5 Europe Fibrinogen Sales Growth
4.6 Middle East & Africa Fibrinogen Sales Growth
5 AMERICAS
5.1 Americas Fibrinogen Sales by Country
5.1.1 Americas Fibrinogen Sales by Country (2020-2025)
5.1.2 Americas Fibrinogen Revenue by Country (2020-2025)
5.2 Americas Fibrinogen Sales by Type (2020-2025)
5.3 Americas Fibrinogen Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Fibrinogen Sales by Region
6.1.1 APAC Fibrinogen Sales by Region (2020-2025)
6.1.2 APAC Fibrinogen Revenue by Region (2020-2025)
6.2 APAC Fibrinogen Sales by Type (2020-2025)
6.3 APAC Fibrinogen Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Fibrinogen by Country
7.1.1 Europe Fibrinogen Sales by Country (2020-2025)
7.1.2 Europe Fibrinogen Revenue by Country (2020-2025)
7.2 Europe Fibrinogen Sales by Type (2020-2025)
7.3 Europe Fibrinogen Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Fibrinogen by Country
8.1.1 Middle East & Africa Fibrinogen Sales by Country (2020-2025)
8.1.2 Middle East & Africa Fibrinogen Revenue by Country (2020-2025)
8.2 Middle East & Africa Fibrinogen Sales by Type (2020-2025)
8.3 Middle East & Africa Fibrinogen Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Fibrinogen
10.3 Manufacturing Process Analysis of Fibrinogen
10.4 Industry Chain Structure of Fibrinogen
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Fibrinogen Distributors
11.3 Fibrinogen Customer
12 WORLD FORECAST REVIEW FOR FIBRINOGEN BY GEOGRAPHIC REGION
12.1 Global Fibrinogen Market Size Forecast by Region
12.1.1 Global Fibrinogen Forecast by Region (2026-2031)
12.1.2 Global Fibrinogen Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Fibrinogen Forecast by Type (2026-2031)
12.7 Global Fibrinogen Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 CSL Behring
13.1.1 CSL Behring Company Information
13.1.2 CSL Behring Fibrinogen Product Portfolios and Specifications
13.1.3 CSL Behring Fibrinogen Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 CSL Behring Main Business Overview
13.1.5 CSL Behring Latest Developments
13.2 LFB Group
13.2.1 LFB Group Company Information
13.2.2 LFB Group Fibrinogen Product Portfolios and Specifications
13.2.3 LFB Group Fibrinogen Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 LFB Group Main Business Overview
13.2.5 LFB Group Latest Developments
13.3 Shanghai RAAS Blood Products
13.3.1 Shanghai RAAS Blood Products Company Information
13.3.2 Shanghai RAAS Blood Products Fibrinogen Product Portfolios and Specifications
13.3.3 Shanghai RAAS Blood Products Fibrinogen Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Shanghai RAAS Blood Products Main Business Overview
13.3.5 Shanghai RAAS Blood Products Latest Developments
13.4 Jiangxi Boya Bio-Pharmaceutical
13.4.1 Jiangxi Boya Bio-Pharmaceutical Company Information
13.4.2 Jiangxi Boya Bio-Pharmaceutical Fibrinogen Product Portfolios and Specifications
13.4.3 Jiangxi Boya Bio-Pharmaceutical Fibrinogen Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Jiangxi Boya Bio-Pharmaceutical Main Business Overview
13.4.5 Jiangxi Boya Bio-Pharmaceutical Latest Developments
13.5 Hualan Biological Engineering
13.5.1 Hualan Biological Engineering Company Information
13.5.2 Hualan Biological Engineering Fibrinogen Product Portfolios and Specifications
13.5.3 Hualan Biological Engineering Fibrinogen Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Hualan Biological Engineering Main Business Overview
13.5.5 Hualan Biological Engineering Latest Developments
13.6 Harbin Pacific Biopharmaceutical
13.6.1 Harbin Pacific Biopharmaceutical Company Information
13.6.2 Harbin Pacific Biopharmaceutical Fibrinogen Product Portfolios and Specifications
13.6.3 Harbin Pacific Biopharmaceutical Fibrinogen Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Harbin Pacific Biopharmaceutical Main Business Overview
13.6.5 Harbin Pacific Biopharmaceutical Latest Developments
13.7 GREEN CROSS
13.7.1 GREEN CROSS Company Information
13.7.2 GREEN CROSS Fibrinogen Product Portfolios and Specifications
13.7.3 GREEN CROSS Fibrinogen Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 GREEN CROSS Main Business Overview
13.7.5 GREEN CROSS Latest Developments
13.8 Shanghai XinXing Medical
13.8.1 Shanghai XinXing Medical Company Information
13.8.2 Shanghai XinXing Medical Fibrinogen Product Portfolios and Specifications
13.8.3 Shanghai XinXing Medical Fibrinogen Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Shanghai XinXing Medical Main Business Overview
13.8.5 Shanghai XinXing Medical Latest Developments
13.9 Taibang Biologic
13.9.1 Taibang Biologic Company Information
13.9.2 Taibang Biologic Fibrinogen Product Portfolios and Specifications
13.9.3 Taibang Biologic Fibrinogen Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Taibang Biologic Main Business Overview
13.9.5 Taibang Biologic Latest Developments
13.10 Octapharma
13.10.1 Octapharma Company Information
13.10.2 Octapharma Fibrinogen Product Portfolios and Specifications
13.10.3 Octapharma Fibrinogen Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Octapharma Main Business Overview
13.10.5 Octapharma Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OFTABLES
Table 1.Fibrinogen Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2.Fibrinogen Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of HumanFibrinogen
Table 4. Major Players of AnimalFibrinogen
Table 5. GlobalFibrinogen Sales byType (2020-2025) & (Kg)
Table 6. GlobalFibrinogen Sales Market Share byType (2020-2025)
Table 7. GlobalFibrinogen Revenue byType (2020-2025) & ($ million)
Table 8. GlobalFibrinogen Revenue Market Share byType (2020-2025)
Table 9. GlobalFibrinogen Sale Price byType (2020-2025) & (US$/g)
Table 10. GlobalFibrinogen Sale by Application (2020-2025) & (Kg)
Table 11. GlobalFibrinogen Sale Market Share by Application (2020-2025)
Table 12. GlobalFibrinogen Revenue by Application (2020-2025) & ($ million)
Table 13. GlobalFibrinogen Revenue Market Share by Application (2020-2025)
Table 14. GlobalFibrinogen Sale Price by Application (2020-2025) & (US$/g)
Table 15. GlobalFibrinogen Sales by Company (2020-2025) & (Kg)
Table 16. GlobalFibrinogen Sales Market Share by Company (2020-2025)
Table 17. GlobalFibrinogen Revenue by Company (2020-2025) & ($ millions)
Table 18. GlobalFibrinogen Revenue Market Share by Company (2020-2025)
Table 19. GlobalFibrinogen Sale Price by Company (2020-2025) & (US$/g)
Table 20. Key ManufacturersFibrinogen Producing Area Distribution and Sales Area
Table 21. PlayersFibrinogen Products Offered
Table 22.Fibrinogen Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. GlobalFibrinogen Sales by Geographic Region (2020-2025) & (Kg)
Table 26. GlobalFibrinogen Sales Market Share Geographic Region (2020-2025)
Table 27. GlobalFibrinogen Revenue by Geographic Region (2020-2025) & ($ millions)
Table 28. GlobalFibrinogen Revenue Market Share by Geographic Region (2020-2025)
Table 29. GlobalFibrinogen Sales by Country/Region (2020-2025) & (Kg)
Table 30. GlobalFibrinogen Sales Market Share by Country/Region (2020-2025)
Table 31. GlobalFibrinogen Revenue by Country/Region (2020-2025) & ($ millions)
Table 32. GlobalFibrinogen Revenue Market Share by Country/Region (2020-2025)
Table 33. AmericasFibrinogen Sales by Country (2020-2025) & (Kg)
Table 34. AmericasFibrinogen Sales Market Share by Country (2020-2025)
Table 35. AmericasFibrinogen Revenue by Country (2020-2025) & ($ millions)
Table 36. AmericasFibrinogen Sales byType (2020-2025) & (Kg)
Table 37. AmericasFibrinogen Sales by Application (2020-2025) & (Kg)
Table 38. APACFibrinogen Sales by Region (2020-2025) & (Kg)
Table 39. APACFibrinogen Sales Market Share by Region (2020-2025)
Table 40. APACFibrinogen Revenue by Region (2020-2025) & ($ millions)
Table 41. APACFibrinogen Sales byType (2020-2025) & (Kg)
Table 42. APACFibrinogen Sales by Application (2020-2025) & (Kg)
Table 43. EuropeFibrinogen Sales by Country (2020-2025) & (Kg)
Table 44. EuropeFibrinogen Revenue by Country (2020-2025) & ($ millions)
Table 45. EuropeFibrinogen Sales byType (2020-2025) & (Kg)
Table 46. EuropeFibrinogen Sales by Application (2020-2025) & (Kg)
Table 47. Middle East & AfricaFibrinogen Sales by Country (2020-2025) & (Kg)
Table 48. Middle East & AfricaFibrinogen Revenue Market Share by Country (2020-2025)
Table 49. Middle East & AfricaFibrinogen Sales byType (2020-2025) & (Kg)
Table 50. Middle East & AfricaFibrinogen Sales by Application (2020-2025) & (Kg)
Table 51. Key Market Drivers & Growth Opportunities ofFibrinogen
Table 52. Key Market Challenges & Risks ofFibrinogen
Table 53. Key IndustryTrends ofFibrinogen
Table 54.Fibrinogen Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56.Fibrinogen Distributors List
Table 57.Fibrinogen Customer List
Table 58. GlobalFibrinogen SalesForecast by Region (2026-2031) & (Kg)
Table 59. GlobalFibrinogen RevenueForecast by Region (2026-2031) & ($ millions)
Table 60. AmericasFibrinogen SalesForecast by Country (2026-2031) & (Kg)
Table 61. AmericasFibrinogen Annual RevenueForecast by Country (2026-2031) & ($ millions)
Table 62. APACFibrinogen SalesForecast by Region (2026-2031) & (Kg)
Table 63. APACFibrinogen Annual RevenueForecast by Region (2026-2031) & ($ millions)
Table 64. EuropeFibrinogen SalesForecast by Country (2026-2031) & (Kg)
Table 65. EuropeFibrinogen RevenueForecast by Country (2026-2031) & ($ millions)
Table 66. Middle East & AfricaFibrinogen SalesForecast by Country (2026-2031) & (Kg)
Table 67. Middle East & AfricaFibrinogen RevenueForecast by Country (2026-2031) & ($ millions)
Table 68. GlobalFibrinogen SalesForecast byType (2026-2031) & (Kg)
Table 69. GlobalFibrinogen RevenueForecast byType (2026-2031) & ($ millions)
Table 70. GlobalFibrinogen SalesForecast by Application (2026-2031) & (Kg)
Table 71. GlobalFibrinogen RevenueForecast by Application (2026-2031) & ($ millions)
Table 72. CSL Behring Basic Information,Fibrinogen Manufacturing Base, Sales Area and Its Competitors
Table 73. CSL BehringFibrinogen Product Portfolios and Specifications
Table 74. CSL BehringFibrinogen Sales (Kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2020-2025)
Table 75. CSL Behring Main Business
Table 76. CSL Behring Latest Developments
Table 77. LFB Group Basic Information,Fibrinogen Manufacturing Base, Sales Area and Its Competitors
Table 78. LFB GroupFibrinogen Product Portfolios and Specifications
Table 79. LFB GroupFibrinogen Sales (Kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2020-2025)
Table 80. LFB Group Main Business
Table 81. LFB Group Latest Developments
Table 82. Shanghai RAAS Blood Products Basic Information,Fibrinogen Manufacturing Base, Sales Area and Its Competitors
Table 83. Shanghai RAAS Blood ProductsFibrinogen Product Portfolios and Specifications
Table 84. Shanghai RAAS Blood ProductsFibrinogen Sales (Kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2020-2025)
Table 85. Shanghai RAAS Blood Products Main Business
Table 86. Shanghai RAAS Blood Products Latest Developments
Table 87. Jiangxi Boya Bio-Pharmaceutical Basic Information,Fibrinogen Manufacturing Base, Sales Area and Its Competitors
Table 88. Jiangxi Boya Bio-PharmaceuticalFibrinogen Product Portfolios and Specifications
Table 89. Jiangxi Boya Bio-PharmaceuticalFibrinogen Sales (Kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2020-2025)
Table 90. Jiangxi Boya Bio-Pharmaceutical Main Business
Table 91. Jiangxi Boya Bio-Pharmaceutical Latest Developments
Table 92. Hualan Biological Engineering Basic Information,Fibrinogen Manufacturing Base, Sales Area and Its Competitors
Table 93. Hualan Biological EngineeringFibrinogen Product Portfolios and Specifications
Table 94. Hualan Biological EngineeringFibrinogen Sales (Kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2020-2025)
Table 95. Hualan Biological Engineering Main Business
Table 96. Hualan Biological Engineering Latest Developments
Table 97. Harbin Pacific Biopharmaceutical Basic Information,Fibrinogen Manufacturing Base, Sales Area and Its Competitors
Table 98. Harbin Pacific BiopharmaceuticalFibrinogen Product Portfolios and Specifications
Table 99. Harbin Pacific BiopharmaceuticalFibrinogen Sales (Kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2020-2025)
Table 100. Harbin Pacific Biopharmaceutical Main Business
Table 101. Harbin Pacific Biopharmaceutical Latest Developments
Table 102. GREEN CROSS Basic Information,Fibrinogen Manufacturing Base, Sales Area and Its Competitors
Table 103. GREEN CROSSFibrinogen Product Portfolios and Specifications
Table 104. GREEN CROSSFibrinogen Sales (Kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2020-2025)
Table 105. GREEN CROSS Main Business
Table 106. GREEN CROSS Latest Developments
Table 107. Shanghai XinXing Medical Basic Information,Fibrinogen Manufacturing Base, Sales Area and Its Competitors
Table 108. Shanghai XinXing MedicalFibrinogen Product Portfolios and Specifications
Table 109. Shanghai XinXing MedicalFibrinogen Sales (Kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2020-2025)
Table 110. Shanghai XinXing Medical Main Business
Table 111. Shanghai XinXing Medical Latest Developments
Table 112.Taibang Biologic Basic Information,Fibrinogen Manufacturing Base, Sales Area and Its Competitors
Table 113.Taibang BiologicFibrinogen Product Portfolios and Specifications
Table 114.Taibang BiologicFibrinogen Sales (Kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2020-2025)
Table 115.Taibang Biologic Main Business
Table 116.Taibang Biologic Latest Developments
Table 117. Octapharma Basic Information,Fibrinogen Manufacturing Base, Sales Area and Its Competitors
Table 118. OctapharmaFibrinogen Product Portfolios and Specifications
Table 119. OctapharmaFibrinogen Sales (Kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2020-2025)
Table 120. Octapharma Main Business
Table 121. Octapharma Latest Developments
LIST OFFIGURES
Figure 1. Picture ofFibrinogen
Figure 2.Fibrinogen Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. GlobalFibrinogen Sales Growth Rate 2020-2031 (Kg)
Figure 7. GlobalFibrinogen Revenue Growth Rate 2020-2031 ($ millions)
Figure 8.Fibrinogen Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9.Fibrinogen Sales Market Share by Country/Region (2024)
Figure 10.Fibrinogen Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of HumanFibrinogen
Figure 12. Product Picture of AnimalFibrinogen
Figure 13. GlobalFibrinogen Sales Market Share byType in 2025
Figure 14. GlobalFibrinogen Revenue Market Share byType (2020-2025)
Figure 15.Fibrinogen Consumed in CongenitalFibrinogen Deficiency
Figure 16. GlobalFibrinogen Market: CongenitalFibrinogen Deficiency (2020-2025) & (Kg)
Figure 17.Fibrinogen Consumed in Surgical Procedures
Figure 18. GlobalFibrinogen Market: Surgical Procedures (2020-2025) & (Kg)
Figure 19.Fibrinogen Consumed in Others
Figure 20. GlobalFibrinogen Market: Others (2020-2025) & (Kg)
Figure 21. GlobalFibrinogen Sale Market Share by Application (2024)
Figure 22. GlobalFibrinogen Revenue Market Share by Application in 2025
Figure 23.Fibrinogen Sales by Company in 2025 (Kg)
Figure 24. GlobalFibrinogen Sales Market Share by Company in 2025
Figure 25.Fibrinogen Revenue by Company in 2025 ($ millions)
Figure 26. GlobalFibrinogen Revenue Market Share by Company in 2025
Figure 27. GlobalFibrinogen Sales Market Share by Geographic Region (2020-2025)
Figure 28. GlobalFibrinogen Revenue Market Share by Geographic Region in 2025
Figure 29. AmericasFibrinogen Sales 2020-2025 (Kg)
Figure 30. AmericasFibrinogen Revenue 2020-2025 ($ millions)
Figure 31. APACFibrinogen Sales 2020-2025 (Kg)
Figure 32. APACFibrinogen Revenue 2020-2025 ($ millions)
Figure 33. EuropeFibrinogen Sales 2020-2025 (Kg)
Figure 34. EuropeFibrinogen Revenue 2020-2025 ($ millions)
Figure 35. Middle East & AfricaFibrinogen Sales 2020-2025 (Kg)
Figure 36. Middle East & AfricaFibrinogen Revenue 2020-2025 ($ millions)
Figure 37. AmericasFibrinogen Sales Market Share by Country in 2025
Figure 38. AmericasFibrinogen Revenue Market Share by Country (2020-2025)
Figure 39. AmericasFibrinogen Sales Market Share byType (2020-2025)
Figure 40. AmericasFibrinogen Sales Market Share by Application (2020-2025)
Figure 41. United StatesFibrinogen Revenue Growth 2020-2025 ($ millions)
Figure 42. CanadaFibrinogen Revenue Growth 2020-2025 ($ millions)
Figure 43. MexicoFibrinogen Revenue Growth 2020-2025 ($ millions)
Figure 44. BrazilFibrinogen Revenue Growth 2020-2025 ($ millions)
Figure 45. APACFibrinogen Sales Market Share by Region in 2025
Figure 46. APACFibrinogen Revenue Market Share by Region (2020-2025)
Figure 47. APACFibrinogen Sales Market Share byType (2020-2025)
Figure 48. APACFibrinogen Sales Market Share by Application (2020-2025)
Figure 49. ChinaFibrinogen Revenue Growth 2020-2025 ($ millions)
Figure 50. JapanFibrinogen Revenue Growth 2020-2025 ($ millions)
Figure 51. South KoreaFibrinogen Revenue Growth 2020-2025 ($ millions)
Figure 52. Southeast AsiaFibrinogen Revenue Growth 2020-2025 ($ millions)
Figure 53. IndiaFibrinogen Revenue Growth 2020-2025 ($ millions)
Figure 54. AustraliaFibrinogen Revenue Growth 2020-2025 ($ millions)
Figure 55. ChinaTaiwanFibrinogen Revenue Growth 2020-2025 ($ millions)
Figure 56. EuropeFibrinogen Sales Market Share by Country in 2025
Figure 57. EuropeFibrinogen Revenue Market Share by Country (2020-2025)
Figure 58. EuropeFibrinogen Sales Market Share byType (2020-2025)
Figure 59. EuropeFibrinogen Sales Market Share by Application (2020-2025)
Figure 60. GermanyFibrinogen Revenue Growth 2020-2025 ($ millions)
Figure 61.FranceFibrinogen Revenue Growth 2020-2025 ($ millions)
Figure 62. UKFibrinogen Revenue Growth 2020-2025 ($ millions)
Figure 63. ItalyFibrinogen Revenue Growth 2020-2025 ($ millions)
Figure 64. RussiaFibrinogen Revenue Growth 2020-2025 ($ millions)
Figure 65. Middle East & AfricaFibrinogen Sales Market Share by Country (2020-2025)
Figure 66. Middle East & AfricaFibrinogen Sales Market Share byType (2020-2025)
Figure 67. Middle East & AfricaFibrinogen Sales Market Share by Application (2020-2025)
Figure 68. EgyptFibrinogen Revenue Growth 2020-2025 ($ millions)
Figure 69. South AfricaFibrinogen Revenue Growth 2020-2025 ($ millions)
Figure 70. IsraelFibrinogen Revenue Growth 2020-2025 ($ millions)
Figure 71.TurkeyFibrinogen Revenue Growth 2020-2025 ($ millions)
Figure 72. GCC CountriesFibrinogen Revenue Growth 2020-2025 ($ millions)
Figure 73. Manufacturing Cost Structure Analysis ofFibrinogen in 2025
Figure 74. Manufacturing Process Analysis ofFibrinogen
Figure 75. Industry Chain Structure ofFibrinogen
Figure 76. Channels of Distribution
Figure 77. GlobalFibrinogen Sales MarketForecast by Region (2026-2031)
Figure 78. GlobalFibrinogen Revenue Market ShareForecast by Region (2026-2031)
Figure 79. GlobalFibrinogen Sales Market ShareForecast byType (2026-2031)
Figure 80. GlobalFibrinogen Revenue Market ShareForecast byType (2026-2031)
Figure 81. GlobalFibrinogen Sales Market ShareForecast by Application (2026-2031)
Figure 82. GlobalFibrinogen Revenue Market ShareForecast by Application (2026-2031)
More Publications
Global Chordal Suture System Market Growth 2024-2030
US$ 3,660.00
December 2024
91 pages
Global Lab Automation in Genomics Market Growth 2024-2030
US$ 3,660.00
December 2024
128 pages
Global Adrenoleukodystrophy Drugs Market Growth 2025-2031
US$ 3,660.00
January 2025
83 pages
Global Biological Skin Substitutes Market Growth (Status and Outlook) 2025-2031
US$ 3,660.00
September 2025
86 pages
Global Medical Protective Goggles Market Growth 2024-2030
US$ 3,660.00
December 2024
117 pages
